Background: We aimed to examine the number of patients diagnosed with dementia during their rehabilitation admission. Dementia can have varying effects on a person's participation in rehabilitation impacting on rehabilitation potential. It is important to disclose a dementia diagnosis to patients and their families to enable future planning as well as availing of support services. Methods: We retrospectively examined all admissions to the Acute Rehabilitation Unit (ARU) over a 12 month period using the online database Bluespiers. We reviewed all patients' records with a diagnosis of dementia. In this cohort additional data including demographics, medications, discharge destination, length of stay and Barthel index pre and post rehab were recorded. Results: 437 patients were admitted to ARU over the study period. 91 (20.8%) had a diagnosis of dementia; 13.2% had the diagnosis prior to admission, 92% of whom were on medications. Those with dementia had a mean age (SD) of 83.69 (5.65) years. Sixtynine (76.7%) patients had neuro-imaging at some point.
We retrospectively examined all admissions to the Acute Rehabilitation Unit (ARU) over a 12 month period using the online database Bluespiers. We reviewed all patients' records with a diagnosis of dementia. In this cohort additional data including demographics, medications, discharge destination, length of stay and Barthel index pre and post rehab were recorded. Results: 437 patients were admitted to ARU over the study period. 91 (20.8%) had a diagnosis of dementia; 13.2% had the diagnosis prior to admission, 92% of whom were on medications. Those with dementia had a mean age (SD) of 83.69 (5.65) years. Sixtynine (76.7%) patients had neuro-imaging at some point. The median (IQR) Barthel Index preadmission was 11/20 (2-20), postadmission 13/ 20 (7-19). The mean (SD) Montreal Cognitive Assessment Score was 14.40 (4.67) with median (IQR) of 14 (6-24). 79.1% (72) of patients returned home, 0.02% (2) back to referring hospital unwell and 18.7% (17) to long-term care. Eighty-one (94.2%) were on anti-dementia medications on discharge; 59.6% (53) on memantine, 11.1% (10) on donepezil, 1.1% (1) on rivastigmine and 5.5% (5) on galantamine. Only 54.9% (50) patients had dementia diagnosis documented on discharge letters to primary care. Conclusion: 1 in 5 patients attending the ARU had a diagnosis of dementia. Rehab potential was good in this population with most patients returning to their own homes. Communication of this diagnosis to patients GP in discharge letters was poor. We hope to put in place a protocol to standardise and improve how we assess and manage patients with dementia in the ARU and re-audit our practice.
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